Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications

Ann Rheum Dis. 2018 Dec;77(12):1835-1836. doi: 10.1136/annrheumdis-2018-213183. Epub 2018 Jul 20.
No abstract available

Keywords: ankylosing spondylitis; anti-tnf; gene polymorphism; rheumatoid arthritis; treatment.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Demyelinating Diseases / chemically induced*
  • Demyelinating Diseases / genetics*
  • Female
  • Genetic Predisposition to Disease / genetics
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis / genetics
  • Polymorphism, Single Nucleotide
  • Receptors, Tumor Necrosis Factor, Type I / genetics*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antirheumatic Agents
  • Receptors, Tumor Necrosis Factor, Type I
  • Tumor Necrosis Factor-alpha